Enalapril: Difference between revisions

(Text replacement - "hx " to "history ")
 
(9 intermediate revisions by 5 users not shown)
Line 1: Line 1:
''Note: for the active metabolite available in IV, see [[Enalaprilat]]''
==General==
==General==
*Type: [[ACE inhibitor]]
*Type: [[ACE inhibitor]]
*Dosage Forms: 2.5, 5, 10, 20
*Dosage Forms: 2.5mg, 5mg, 10mg, 20mg
*Common Trade Names: Vasotec, Epaned
*Common Trade Names: Vasotec, Epaned


General information:  
General information:  
*Doses > 40 mg/day rarely more effective
*Doses > 40mg/day rarely more effective
*Decreased efficacy as mono therapy in african-american patients
*Decreased efficacy as monotherapy in African-American patients
*Obtain Chem 10 if starting in ED to assess renal function
*Obtain Chem 10 if starting in ED to assess renal function


==Adult Dosing==
==Adult Dosing==
*HTN: 10 - 40 mg PO Qday, max 40 mg/day
*hypertension: 10 - 40mg PO Qday, max 40mg/day


==Pediatric Dosing==
==Pediatric Dosing==
*1 month -16 year old: 0.1 - 0.5 mg/kg/day PO divided q12 - 24h, max 40 mg/day
*1 month -16 year old: 0.1 - 0.5mg/kg/day PO divided q12 - 24h, max 40mg/day


==Special Populations==
==Special Populations==
Line 19: Line 20:
*Lactation: Probably Safe
*Lactation: Probably Safe
*Renal Dosing
*Renal Dosing
**Adult: CrCl < 30, start 2.5 mg qday, max 40 mg q/day
**Adult: CrCl < 30, start 2.5mg qday, max 40mg q/day
**Pediatric Cr Cl 10-50: decrease dose 25%, CrCl < 10: decrease dose 50%
**Pediatric creatinine Cl 10-50: decrease dose 25%, CrCl < 10: decrease dose 50%
*Hepatic Dosing
*Hepatic Dosing
**Adult: Not defined
**Adult: Not defined
Line 61: Line 62:


==See Also==
==See Also==
*[[Hypertension]]
*[[ACE inhibitor]]


==References==
==References==
<references/>


<references/>
[[Category:Pharmacology]]
[[Category:Pharmacology]]
[[Category:Cardiology]]

Latest revision as of 15:57, 8 March 2021

Note: for the active metabolite available in IV, see Enalaprilat

General

  • Type: ACE inhibitor
  • Dosage Forms: 2.5mg, 5mg, 10mg, 20mg
  • Common Trade Names: Vasotec, Epaned

General information:

  • Doses > 40mg/day rarely more effective
  • Decreased efficacy as monotherapy in African-American patients
  • Obtain Chem 10 if starting in ED to assess renal function

Adult Dosing

  • hypertension: 10 - 40mg PO Qday, max 40mg/day

Pediatric Dosing

  • 1 month -16 year old: 0.1 - 0.5mg/kg/day PO divided q12 - 24h, max 40mg/day

Special Populations

  • Pregnancy Rating: D
  • Lactation: Probably Safe
  • Renal Dosing
    • Adult: CrCl < 30, start 2.5mg qday, max 40mg q/day
    • Pediatric creatinine Cl 10-50: decrease dose 25%, CrCl < 10: decrease dose 50%
  • Hepatic Dosing
    • Adult: Not defined
    • Pediatric: Not defined

Contraindications

  • Allergy to class/drug
  • history of angioedema
  • pregnancy
  • caution if renal artery stenosis
  • caution if severe CHF
  • caution if renal impairment

Adverse Reactions

Serious

  • angioedema
  • hypotension
  • hyperkalemia
  • renal impairment
  • hepatotoxicity
  • neutropenia
  • pancreatitis
  • steven johnson syndrome
  • fetal/neonatal harm
  • congenital malformations

Common

  • dizziness
  • elevated Cr
  • headache
  • diarrhea
  • hypotension
  • abdominal pain
  • hyperkalemia

Pharmacology

  • Half-life: 12 hours
  • Metabolism: Liver
  • Excretion: urine, feces
  • Mechanism of Action: inhibits angiotensin converting enzyme, interferes with conversion of angiotensin 1 to angiotensin 2

See Also

References